ArticleJournal of hepatocellular carcinoma2024

PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study.

Dazhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.